China H2 2019 Outlook

Cutting through the noise

UBS Asset Management's China investment experts got together with over 100 clients from banks and financial institutions at our exclusive Viewpoints Luncheon in Hong Kong on June 25th to chart the outlook for H2 2019 and outline investor opportunities.

Key takeaways

  • The US Fed will likely make one-to-two interest rate cuts in H2 2019
  • US-China tensions not just limited to trade, rivalry will continue and make for lasting market volatility
  • China's property sector is in good shape: demand is outstripping supply and we're still positive on larger developers
  • Stimulus measures have put a base under the economy and we see an improving growth outlook for China in H2 2019
  • Further policy support likely, such as cuts to interest rates/RRR
  • Long run-drivers for China's economy remain intact, China equity valuations reasonable by historical measures
  • Tweets are driving newsflow - particularly on the trade issue – but investors should cut through the noise and remember that fundamentals drive economies and the above factors offer many compelling reasons to be long-term positive on China

China macro: the L-shaped recovery

Hayden Briscoe, Head of Asia Pacific Fixed Income, started proceedings by reiterating his view in a L-shaped recovery for China in H2 2019. Policy stimulus has put a support under the economy and he expects the real effects of the stimulus will become clear in headline macro numbers in H2 2019.

Going further, Briscoe expects China to provide further support in the coming months, most likely via cuts to interest rates and reserve requirement ratios, and these will be important policy moves because of the likelihood that US-imposed trade tariffs will hit the trade sector, and also because of a likely slowdown in global growth.

China fixed income: strong case for government bonds; high yield offers attractive relative valuation

How should investors react to the slowing global backdrop? Briscoe explained that China's government bond markets offer investors some of the highest nominal and real yields in the world, in stark contrast to negative yields on German and Japanese government bonds.     

Briscoe also showed that China high yield looks good on a relative value basis to US and European high yield. Looking at real estate sector - which dominates Asia high yield - Briscoe favors large Chinese developers, many of whom are seeing improving revenue and interest coverage.

Bin Shi: US-China rivalry likely to continue

Bin Shi, Head of China Equities, warned investors not to be overly focused on a solution to US-China trade issues at the G-20 meeting at the end of June. Bin repeatedly explained that US-China tensions are not just limited to trade tariffs, but are part of a rivalry that will continue and make for lasting market volatility.

Bin also stressed that though the US is pressuring China, the pressure may push the Chinese government to accelerate market liberalization and structural reforms, which could be positive for China in the long run. 

Bin Shi: good companies unexposed to trade tensions available at reasonable valuations; All-China approach makes sense

Bin also emphasized that the current environment means it is even more important to focus on finding the right companies. Bin reasoned that there are many companies in China who have very little exposure to US markets and who will continue to do well in a very uncertain environment.

Long-run drivers, like urbanization, ageing and R&D-driven innovation, still remain intact – despite US trade policy pressure – and that means it is possible to find good companies attached to these trends. Additionally, many of these companies are trading at reasonable valuations.

Moving onto strategy, Bin explained that when accessing the best opportunities on China's equity markets, taking an All-China approach to equity investing may be the best strategy. Such an approach flexibly allocates to the best China equity opportunities, whether onshore or offshore, now that China's onshore markets have become accessible to overseas investors.    

Gian Plebani and the multi-asset view

Gian Plebani, Portfolio Manager for UBS AM multi-asset portfolios, explained that he's bullish on China assets over a six-to-twelve month time horizon. Plebani cited two key factors: firstly, the improvement in global liquidity as central banks across the world turn more dovish and, secondly, the stimulus that the Chinese government is putting into the economy.

Looking at China's stimulus in more detail. Plebani cited looser monetary policy, infrastructure investments, and tax cuts for companies and individuals, as amounting to strong policy support for the economy. Going further, Plebani pointed to a turning point in leading indicators that he has seen during the past six months, which indicate to him that it is time to start allocating to risk assets.

Trade issues are complicating the outlook though. Hence Plebani is keeping a short-term neutral allocation to overall risk in the portfolio until there is more clarity on immediate trade developments. Plebani favors A-shares because they are more sensitive to the stimulus the Chinese government is providing to the domestic economy. Additionally, high-yield fixed income is a favored asset class, mainly because of improving liquidity conditions in China. Finally, Plebani said he was underweight on the RMB because of the risk of a devaluation in the currency.

What's the outlook for Fed policy?

Entering into a Q&A, our experts discussed their expectations for Fed policy and here are the stand-out quotes:

"We expect one-to-two cuts from the Fed this year. That's good for China because it gives the Chinese authorities room to also cut interest rates, and they have had limited room to do that in the past couple of years. If these cuts happen, we will see a reflation in risk assets both globally and in China."

Gian Plebani

 

"We also expect one-to-two cuts from the Fed. However, we doubt the efficacy of rate cuts right now, with interest rates globally at such low levels. We wouldn't be surprised to see the debate about global macro shifting quickly to currency policy."

Hayden Briscoe

More insights


Hayden Briscoe

Head of Fixed Income, Asia Pacific

Gian Plebani

Portfolio Manager, Investment Solutions

What’s your expectations for US-China trade tensions in the next 3 – 6 months?

60% of respondents to a live poll of our audience of financial professionals in Hong Kong expected disappointing discussions and partial escalation of US-China trade tensions in the next three-to-six months.

What do you expect?

Take our survey here:

What’s your expectation for US-China trade tensions in the next 3 – 6 months?

Poll Form

Hong Kong Professional Investors

For marketing and information purposes by UBS. For professional investors only. This document does not replace portfolio and fund-specific materials. Commentary is at a macro or strategy level and is not with reference to any registered or other mutual fund.

This document and its contents have not been reviewed, delivered to or registered with any regulatory or other relevant authority in Hong Kong. This document is for informational purposes and should not be construed as an offer or invitation to the public, direct or indirect, to buy or sell securities. This document is intended for limited distribution and only to the extent permitted under applicable laws in Hong Kong. No representations are made with respect to the eligibility of any recipients of this document to acquire interests in securities under the laws of Hong Kong.

Using, copying, redistributing or republishing any part of this document without prior written permission from UBS Asset Management is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this document is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this document are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS Asset Management’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

You are advised to exercise caution in relation to this document. The information in this document does not constitute advice and does not take into consideration your investment objectives, legal, financial or tax situation or particular needs in any other respect. Investors should be aware that past performance of investment is not necessarily indicative of future performance. Potential for profit is accompanied by possibility of loss. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice.

Hong Kong: This document and its contents have not been reviewed by any regulatory authority in Hong Kong. No person may issue any invitation, advertisement or other document relating to the interests whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the interests which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571) and the Securities and Futures (Professional Investor) Rules made thereunder.

The materials on this Website are distributed by UBS Asset Management (Hong Kong) Limited, which is licensed by the Securities and Futures Commission ("SFC") [CE Number AGP568] in the Hong Kong Special Administrative Region of the People's Republic of  China ("Hong Kong") pursuant to the Securities and Futures Ordinance (Cap 571).  UBS Asset Management (Hong Kong) Limited is a part of the Asset Management business division of UBS Group AG. UBS Asset Management (Hong Kong) Limited together with UBS Group AG and its group companies shall collectively be referred to as "UBS". The material contained in this Website has not been reviewed by the SFC or any regulatory authority in Hong Kong.

The information contained in this Website has been prepared and is intended for general circulation. The information does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy.

UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS' judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance. The information in this Website does not constitute advice and does not take into consideration your investment objectives, legal, financial or tax situation or particular needs in any other respect. You will conduct your own evaluation and consult with your own legal, business and tax advisors to determine the appropriateness and consequences of any investment and you will make any investment pursuant to an independent evaluation and analysis of the consequences of the same in reliance only upon your own judgment and not in reliance upon this website. Potential for profit is accompanied by possibility of loss. You may wish to seek advice from a financial adviser regarding the suitability of the Funds before making a commitment to purchase units or shares in the Funds. In the event you choose not to do so, you should consider whether the Fund is suitable for you. UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment. Please contact UBS Asset Management (Hong Kong) Limited or our appointed distributors for more information on how to subscribe for units or shares in the Funds.

Without prejudice to the foregoing or to the provisions of the Global Terms of Use, this Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website are authorized by the SFC for sale to the public in Hong Kong (the “Funds”). UBS Asset Management (Hong Kong) Limited is the appointed Hong Kong Representative of the Funds. SFC authorization is not a recommendation or endorsement of the Funds nor does it guarantee the commercial merit or performance of the Funds. It does not mean that the Funds are suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors.

This materials on this Website and its contents have not been reviewed by, delivered to or registered with any regulatory or other relevant authority in Hong Kong. This Website is for informational purposes and should not be construed as an offer or invitation to the public, direct or indirect, to buy or sell securities. This document is intended for limited distribution and only to the extent permitted under applicable laws in Hong Kong. No representations are made with respect to the eligibility of any recipients of this document to acquire interests in securities under the laws of Hong Kong.

Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance. The offering document or prospectus for each of the Funds should be read for further details. If you are unsure about the meaning of any information in the offering document or prospectus of the Funds, provided please consult with your financial or other professional adviser.

You may not assign your rights under these Terms without our prior written consent. UBS Asset Management (Hong Kong) Limited may assign our rights under these Terms to any third party.

No person or entity who is not a party to these Terms shall have any right under the Contracts (Rights of Third Parties) Ordinance (Cap. 623) of Hong Kong or other similar laws to enforce any term of these Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of these Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Hong Kong. The courts of Hong Kong shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Hong Kong.  Each party hereby waives any objection which it might at any time have to the courts of Hong Kong being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2019 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

This website contains general information on UBS Asset Management. For information specific to Professional Investors, please refer to the Funds and prices page.

Reset